Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 40,572 | 10,457 | 13,467 | 4,119 | 9,795 |
| Gross Profit | 40,572 | 10,457 | 13,467 | 4,119 | 9,795 |
| Operating Expenses | 74,856 | 49,953 | 33,012 | 27,612 | 31,434 |
| Operating Income | -34,284 | -39,496 | -19,544 | -23,494 | -21,639 |
| Other Income | 3,083 | 3,356 | -46,539 | 3,781 | 6,334 |
| Pre-tax Income | -31,201 | -36,140 | -66,084 | -19,713 | -15,304 |
| Income Tax | -2,098 | 0 | 0 | N/A | N/A |
| Net Income Continuous | -29,103 | -36,140 | -66,084 | -19,713 | -15,304 |
| Minority Interests | 85 | -18 | -55 | -44 | -51 |
| Net Income | $-29,188 | $-36,122 | $-66,029 | $-19,669 | $-15,253 |
| EPS Basic Total Ops | -5.16 | -7.32 | -17.17 | -6.96 | -5.76 |
| EPS Basic Continuous Ops | -5.12 | -7.34 | -17.21 | -6.93 | -5.82 |
| EPS Diluted Total Ops | -5.28 | -7.68 | -17.17 | -6.96 | -5.76 |
| EPS Diluted Continuous Ops | -5.11 | -7.30 | -17.21 | -6.93 | -5.82 |
| EBITDA(a) | $-32,017 | $-37,872 | $-17,446 | $-21,499 | $-19,627 |